Researchers reported that the first CV-19 vaccine to be tested in the US has produced promising results.
The study, tested on 45 healthy adults, produced encouraging effects on the immune system.
A second, larger trial run by President Trump's advisor, Dr. Fauci, is said to begin around July 27.